Precision Biosciences Inc. (DTIL)
NASDAQ · Healthcare
Precision Biosciences Inc. Operating Income 2018–2025
Precision Biosciences Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Precision Biosciences Inc. operating income for the quarter ending March 31, 2026 was -9.1 M, a 58.96% decrease year-over-year.
- Precision Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -73.7 M, a 439.01% increase year-over-year.
- Precision Biosciences Inc. annual operating income for 2025 was -52.1 M, a 99.33% increase from 2024.
- Precision Biosciences Inc. annual operating income for 2024 was -26.2 M, a 40.18% decrease from 2023.
- Precision Biosciences Inc. annual operating income for 2023 was -43.7 M, a 29.81% decrease from 2022.
- Precision Biosciences Inc. annual operating income for 2022 was -62.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Precision Biosciences Inc. Operating Income — FAQ
Precision Biosciences Inc. (DTIL) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Precision Biosciences Inc.'s operating income?
Precision Biosciences Inc. (DTIL) reported operating income of -$52M for fiscal 2025.
Where can I see DTIL's operating income history?
The chart and table above show Precision Biosciences Inc.'s operating income by year and by quarter, including the growth rate.